FDA product code · General and plastic surgery
Laser For Disruption Of Adipocyte Cells For Aesthetic Use
19 FDA decisions since 2015. 510(k) reviews decided 2021–2025 took a median of 85 days (half between 66 and 123). No recall names this code. The most-cited predicate is K160470, named by 4 later devices.
Laser intended for the disruption of adipocyte cells indicated for body contouring or reduction in circumference of body areas.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly Download the data (CSV)
Twenty years of PKT at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.
FDA decisions per year · PKT
2in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · PKT
85in 2023
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · PKT
No recall names PKT since 2007.
Adverse event reports per year · PKT
5in 2025
MAUDE reports naming product code PKT, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 2 | — | 0 | 0 |
| 2016 | 1 | — | 0 | 7 |
| 2017 | 2 | — | 0 | 10 |
| 2018 | 0 | — | 0 | 16 |
| 2019 | 3 | 97 | 0 | 13 |
| 2020 | 2 | — | 0 | 5 |
| 2021 | 2 | — | 0 | 6 |
| 2022 | 2 | — | 0 | 4 |
| 2023 | 3 | 85 | 0 | 0 |
| 2024 | 2 | — | 0 | 4 |
| 2025 | 0 | — | 0 | 5 |
| 2026 | 0 | — | 0 | — |
Planning a device in PKT? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportRelated product codes
Other codes under 21 CFR 878.5400.